img

Global Nilotinib Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Nilotinib Market Research Report 2024

Nilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). 
According to Mr Accuracy reports new survey, global Nilotinib market is projected to reach US$ 1200.7 million in 2029, increasing from US$ 1923 million in 2022, with the CAGR of -5.4% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Nilotinib market research.
Tasigna, a targeted therapy used in the treatment of certain types of leukemia, is witnessing increasing demand. Factors driving market growth include the rising incidence of leukemia, advancements in precision medicine, and the efficacy of Tasigna in treating resistant forms of the disease. Key players in the market are investing in research and development to expand the indications of Tasigna and explore its potential in combination therapies. Additionally, strategic collaborations and regulatory approvals are contributing to market expansion. However, challenges such as high treatment costs and the availability of generic alternatives may impact market growth.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Nilotinib market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Novartis
Segment by Type
50mg
200mg
Other

Segment by Application


Hospital
Drugs Store
Other

Consumption by Region


North America
the United States
Canada
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Nilotinib report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Nilotinib Market Overview
1.1 Product Overview and Scope of Nilotinib
1.2 Nilotinib Segment by Type
1.2.1 Global Nilotinib Market Value Comparison by Type (2024-2034)
1.2.2 50mg
1.2.3 200mg
1.2.4 Other
1.3 Nilotinib Segment by Application
1.3.1 Global Nilotinib Market Value by Application: (2024-2034)
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Global Nilotinib Market Size Estimates and Forecasts
1.4.1 Global Nilotinib Revenue 2018-2029
1.4.2 Global Nilotinib Sales 2018-2029
1.4.3 Global Nilotinib Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nilotinib Market Competition by Manufacturers
2.1 Global Nilotinib Sales Market Share by Manufacturers (2018-2024)
2.2 Global Nilotinib Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Nilotinib Average Price by Manufacturers (2018-2024)
2.4 Global Nilotinib Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Nilotinib, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nilotinib, Product Type & Application
2.7 Nilotinib Market Competitive Situation and Trends
2.7.1 Nilotinib Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nilotinib Players Market Share by Revenue
2.7.3 Global Nilotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nilotinib Retrospective Market Scenario by Region
3.1 Global Nilotinib Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nilotinib Global Nilotinib Sales by Region: 2018-2029
3.2.1 Global Nilotinib Sales by Region: 2018-2024
3.2.2 Global Nilotinib Sales by Region: 2024-2029
3.3 Global Nilotinib Global Nilotinib Revenue by Region: 2018-2029
3.3.1 Global Nilotinib Revenue by Region: 2018-2024
3.3.2 Global Nilotinib Revenue by Region: 2024-2029
3.4 North America Nilotinib Market Facts & Figures by Country
3.4.1 North America Nilotinib Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nilotinib Sales by Country (2018-2029)
3.4.3 North America Nilotinib Revenue by Country (2018-2029)
3.4.4 the United States
3.4.5 Canada
3.5 Europe Nilotinib Market Facts & Figures by Country
3.5.1 Europe Nilotinib Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nilotinib Sales by Country (2018-2029)
3.5.3 Europe Nilotinib Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 UK
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nilotinib Market Facts & Figures by Country
3.6.1 Asia Pacific Nilotinib Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nilotinib Sales by Country (2018-2029)
3.6.3 Asia Pacific Nilotinib Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Nilotinib Market Facts & Figures by Country
3.7.1 Latin America Nilotinib Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nilotinib Sales by Country (2018-2029)
3.7.3 Latin America Nilotinib Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nilotinib Market Facts & Figures by Country
3.8.1 Middle East and Africa Nilotinib Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nilotinib Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nilotinib Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nilotinib Sales by Type (2018-2029)
4.1.1 Global Nilotinib Sales by Type (2018-2024)
4.1.2 Global Nilotinib Sales by Type (2024-2029)
4.1.3 Global Nilotinib Sales Market Share by Type (2018-2029)
4.2 Global Nilotinib Revenue by Type (2018-2029)
4.2.1 Global Nilotinib Revenue by Type (2018-2024)
4.2.2 Global Nilotinib Revenue by Type (2024-2029)
4.2.3 Global Nilotinib Revenue Market Share by Type (2018-2029)
4.3 Global Nilotinib Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nilotinib Sales by Application (2018-2029)
5.1.1 Global Nilotinib Sales by Application (2018-2024)
5.1.2 Global Nilotinib Sales by Application (2024-2029)
5.1.3 Global Nilotinib Sales Market Share by Application (2018-2029)
5.2 Global Nilotinib Revenue by Application (2018-2029)
5.2.1 Global Nilotinib Revenue by Application (2018-2024)
5.2.2 Global Nilotinib Revenue by Application (2024-2029)
5.2.3 Global Nilotinib Revenue Market Share by Application (2018-2029)
5.3 Global Nilotinib Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Corporation Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Nilotinib Sales, Revenue and Gross Margin (2018-2024)
6.1.4 Novartis Nilotinib Product Portfolio
6.1.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nilotinib Industry Chain Analysis
7.2 Nilotinib Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nilotinib Production Mode & Process
7.4 Nilotinib Sales and Marketing
7.4.1 Nilotinib Sales Channels
7.4.2 Nilotinib Distributors
7.5 Nilotinib Customers
8 Nilotinib Market Dynamics
8.1 Nilotinib Industry Trends
8.2 Nilotinib Market Drivers
8.3 Nilotinib Market Challenges
8.4 Nilotinib Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Nilotinib Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Nilotinib Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Nilotinib Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nilotinib Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Nilotinib Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Nilotinib Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Nilotinib Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Nilotinib Average Price (USD/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Nilotinib, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Nilotinib, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nilotinib, Product Type & Application
Table 12. Global Key Manufacturers of Nilotinib, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nilotinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nilotinib as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nilotinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nilotinib Sales by Region (2018-2024) & (K Units)
Table 18. Global Nilotinib Sales Market Share by Region (2018-2024)
Table 19. Global Nilotinib Sales by Region (2024-2029) & (K Units)
Table 20. Global Nilotinib Sales Market Share by Region (2024-2029)
Table 21. Global Nilotinib Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Nilotinib Revenue Market Share by Region (2018-2024)
Table 23. Global Nilotinib Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nilotinib Revenue Market Share by Region (2024-2029)
Table 25. North America Nilotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nilotinib Sales by Country (2018-2024) & (K Units)
Table 27. North America Nilotinib Sales by Country (2024-2029) & (K Units)
Table 28. North America Nilotinib Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Nilotinib Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nilotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nilotinib Sales by Country (2018-2024) & (K Units)
Table 32. Europe Nilotinib Sales by Country (2024-2029) & (K Units)
Table 33. Europe Nilotinib Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Nilotinib Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nilotinib Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nilotinib Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Nilotinib Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Nilotinib Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Nilotinib Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nilotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nilotinib Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Nilotinib Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Nilotinib Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Nilotinib Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nilotinib Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nilotinib Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Nilotinib Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Nilotinib Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Nilotinib Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nilotinib Sales (K Units) by Type (2018-2024)
Table 51. Global Nilotinib Sales (K Units) by Type (2024-2029)
Table 52. Global Nilotinib Sales Market Share by Type (2018-2024)
Table 53. Global Nilotinib Sales Market Share by Type (2024-2029)
Table 54. Global Nilotinib Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Nilotinib Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nilotinib Revenue Market Share by Type (2018-2024)
Table 57. Global Nilotinib Revenue Market Share by Type (2024-2029)
Table 58. Global Nilotinib Price (USD/Unit) by Type (2018-2024)
Table 59. Global Nilotinib Price (USD/Unit) by Type (2024-2029)
Table 60. Global Nilotinib Sales (K Units) by Application (2018-2024)
Table 61. Global Nilotinib Sales (K Units) by Application (2024-2029)
Table 62. Global Nilotinib Sales Market Share by Application (2018-2024)
Table 63. Global Nilotinib Sales Market Share by Application (2024-2029)
Table 64. Global Nilotinib Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Nilotinib Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nilotinib Revenue Market Share by Application (2018-2024)
Table 67. Global Nilotinib Revenue Market Share by Application (2024-2029)
Table 68. Global Nilotinib Price (USD/Unit) by Application (2018-2024)
Table 69. Global Nilotinib Price (USD/Unit) by Application (2024-2029)
Table 70. Novartis Corporation Information
Table 71. Novartis Description and Business Overview
Table 72. Novartis Nilotinib Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 73. Novartis Nilotinib Product
Table 74. Novartis Recent Developments/Updates
Table 75. Key Raw Materials Lists
Table 76. Raw Materials Key Suppliers Lists
Table 77. Nilotinib Distributors List
Table 78. Nilotinib Customers List
Table 79. Nilotinib Market Trends
Table 80. Nilotinib Market Drivers
Table 81. Nilotinib Market Challenges
Table 82. Nilotinib Market Restraints
Table 83. Research Programs/Design for This Report
Table 84. Key Data Information from Secondary Sources
Table 85. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nilotinib
Figure 2. Global Nilotinib Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Nilotinib Market Share by Type in 2022 & 2029
Figure 4. 50mg Product Picture
Figure 5. 200mg Product Picture
Figure 6. Other Product Picture
Figure 7. Global Nilotinib Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Nilotinib Market Share by Application in 2022 & 2029
Figure 9. Hospital
Figure 10. Drugs Store
Figure 11. Other
Figure 12. Global Nilotinib Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Nilotinib Market Size (2018-2029) & (US$ Million)
Figure 14. Global Nilotinib Sales (2018-2029) & (K Units)
Figure 15. Global Nilotinib Average Price (USD/Unit) & (2018-2029)
Figure 16. Nilotinib Report Years Considered
Figure 17. Nilotinib Sales Share by Manufacturers in 2022
Figure 18. Global Nilotinib Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Nilotinib Players: Market Share by Revenue in 2022
Figure 20. Nilotinib Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Nilotinib Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Nilotinib Sales Market Share by Country (2018-2029)
Figure 23. North America Nilotinib Revenue Market Share by Country (2018-2029)
Figure 24. the United States Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Nilotinib Sales Market Share by Country (2018-2029)
Figure 27. Europe Nilotinib Revenue Market Share by Country (2018-2029)
Figure 28. Germany Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. UK Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Nilotinib Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Nilotinib Revenue Market Share by Region (2018-2029)
Figure 35. China Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Nilotinib Sales Market Share by Country (2018-2029)
Figure 45. Latin America Nilotinib Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Nilotinib Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Nilotinib Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Nilotinib Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Nilotinib by Type (2018-2029)
Figure 55. Global Revenue Market Share of Nilotinib by Type (2018-2029)
Figure 56. Global Nilotinib Price (USD/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Nilotinib by Application (2018-2029)
Figure 58. Global Revenue Market Share of Nilotinib by Application (2018-2029)
Figure 59. Global Nilotinib Price (USD/Unit) by Application (2018-2029)
Figure 60. Nilotinib Value Chain
Figure 61. Nilotinib Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed